You are here:Home1/Lisa Egbuonu-Davis – Faculty – IFAPP Academy
MD, MPH, MBA
Vice President, Medical Innovations, Danaher Diagnostics Platform
Lisa Egbuonu-Davis, MD, MPH, MBA, Vice President, Medical Innovations, Danaher Diagnostics Platform, provides medical and clinical input to the innovation strategy, projects, and investments across the Diagnostics platform. She leads the MD Council of diagnostic physicians, which enhances the medical value of our solutions by influencing strategy and investment decisions, driving engagement, and sharing best practices to support product research, development, and commercialization. She leads the COVID Diagnostic Platform clinical strategic initiative.
Previously, Lisa was Vice President, Global Patient-Centered Outcomes and Solutions at Sanofi, Inc, where she created innovative patient programs, services, and tools to enhance patient self-management, adherence, and health outcomes in diabetes, cardiovascular, immunologic, and other chronic conditions. She led a pilot in multiple sclerosis, leveraging machine learning to assess patterns of clinical effectiveness. During her tenure at Pfizer, as Vice President of Medical Affairs and Vice Present of Global Outcomes Research, she built and led functions in medical affairs and outcomes research and developed evidence from clinical trials, observational studies, and “real world” analyses to support product value assessment throughout the product life cycle. Earlier in her career, she practiced pediatrics and led maternal and child health public health programs.
Lisa has a BS in biology from MIT and an MBA in health care management from Wharton; she earned an MD and MPH (epidemiology) degrees from Johns Hopkins, completed her pediatric residency at Children’s Hospital of Philadelphia (board-certified in pediatrics).
IFAPP Academy provides an online, continuing professional development course, Medical Affairs in Medicines Development, resulting in the Professional Certification, Certified Medicines Development (CMD).